RASSF1 and hepatocellular carcinoma: Further, the impact of the promoter hypermethylation of RASSF1A within cancer tissues on the risk and clinicopathological characteristics of HCC has not been summarized yet, and there was a need for the association of the promoter hypermethylation of RASSF1A with HCC prognoses to be analyzed.